ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
3 announcements with these filters
Novartis India acquired trademarks 'Minipress' and 'Minipres' from Pfizer for ₹1,250.001 Crore. The IP acquisition strengthens its hypertension and BPH portfolio in India.
Novartis India terminated its 2022 distribution agreement with Dr. Reddy's Laboratories, effective September 30, 2026. The company will now re-acquire exclusive product distribution and marketing rights.
Novartis India executed a royalty-free license deed for the 'Tegrital' trademark. This agreement allows the company to manufacture and market the Tegrital pharmaceutical product range.